Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Henderson

Showing results (61-70 of 161) with videos related to

Pageof 17
Sort By:
The Journal of Clinical Psychiatry|January 7, 2011
Triglyceride/high-density lipoprotein cholesterol ratio: a surrogate to predict insulin resistance and low-density lipoprotein cholesterol particle size in nondiabetic patients with schizophreniaXiaoduo Fan, Emily Y Liu, Vicki Poole Hoffman, et al.
Patient Related Outcome Measures|June 28, 2017
Initial development of a patient-reported outcome measure of experience with cognitive impairment associated with schizophreniaLisa C Welch, Jeremiah J Trudeau, Steven M Silverstein, et al.
Health and Quality of Life Outcomes|May 10, 2017
Quality of life of depressed and suicidal patients seeking services from traditional and faith healers in rural KenyaChristine W Musyimi, Victoria N Mutiso, Sameera S Nayak, et al.
Harvard Review of Psychiatry|February 17, 2012
Capacity building in global mental health: professional trainingGregory L Fricchione, Christina P C Borba, Atalay Alem, et al.
Psychopharmacology|March 22, 2005
Added donepezil for stable schizophrenia: a double-blind, placebo-controlled trialOliver Freudenreich, Lawrence Herz, Thilo Deckersbach, et al.
Psychotherapy (Chicago, Ill.)|August 19, 2021
Psychotherapy in a resource-constrained setting: Understanding context for adapting and integrating a brief psychological intervention into primary careKimberly Hook, Amantia Ametaj, Yuhan Cheng, et al.
Journal of Public Health Management and Practice : JPHMP|December 4, 2018
The HEAAL Project: Applying Community-Based Participatory Research (CBPR) Methodology in a Health and Mental Health Needs Assessment With an African Immigrant and Refugee Faith Community in Lowell, MassachusettsClaire E Oppenheim, Kathleen Axelrod, Jeremiah Menyongai, et al.
Journal of Clinical Psychopharmacology|February 11, 2016
Efficacy, Safety, and Tolerability of RBP-7000 Once-Monthly Risperidone for the Treatment of Acute Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 StudyAzmi F Nasser, David C Henderson, Maurizio Fava, et al.
Journal of Clinical Psychopharmacology|February 25, 2011
No effect of single-dose intranasal insulin treatment on verbal memory and sustained attention in patients with schizophreniaXiaoduo Fan, Paul M Copeland, Emily Y Liu, et al.
Psychopharmacology|August 22, 2008
A placebo-controlled study of sildenafil effects on cognition in schizophreniaDonald C Goff, Corinne Cather, Oliver Freudenreich, et al.
Pageof 17

Showing results (61-70 of 161) with videos related to

Sort By:
Pageof 17
The Journal of Clinical Psychiatry|January 7, 2011
Triglyceride/high-density lipoprotein cholesterol ratio: a surrogate to predict insulin resistance and low-density lipoprotein cholesterol particle size in nondiabetic patients with schizophreniaXiaoduo Fan, Emily Y Liu, Vicki Poole Hoffman, et al.
Patient Related Outcome Measures|June 28, 2017
Initial development of a patient-reported outcome measure of experience with cognitive impairment associated with schizophreniaLisa C Welch, Jeremiah J Trudeau, Steven M Silverstein, et al.
Health and Quality of Life Outcomes|May 10, 2017
Quality of life of depressed and suicidal patients seeking services from traditional and faith healers in rural KenyaChristine W Musyimi, Victoria N Mutiso, Sameera S Nayak, et al.
Harvard Review of Psychiatry|February 17, 2012
Capacity building in global mental health: professional trainingGregory L Fricchione, Christina P C Borba, Atalay Alem, et al.
Psychopharmacology|March 22, 2005
Added donepezil for stable schizophrenia: a double-blind, placebo-controlled trialOliver Freudenreich, Lawrence Herz, Thilo Deckersbach, et al.
Psychotherapy (Chicago, Ill.)|August 19, 2021
Psychotherapy in a resource-constrained setting: Understanding context for adapting and integrating a brief psychological intervention into primary careKimberly Hook, Amantia Ametaj, Yuhan Cheng, et al.
Journal of Public Health Management and Practice : JPHMP|December 4, 2018
The HEAAL Project: Applying Community-Based Participatory Research (CBPR) Methodology in a Health and Mental Health Needs Assessment With an African Immigrant and Refugee Faith Community in Lowell, MassachusettsClaire E Oppenheim, Kathleen Axelrod, Jeremiah Menyongai, et al.
Journal of Clinical Psychopharmacology|February 11, 2016
Efficacy, Safety, and Tolerability of RBP-7000 Once-Monthly Risperidone for the Treatment of Acute Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 StudyAzmi F Nasser, David C Henderson, Maurizio Fava, et al.
Journal of Clinical Psychopharmacology|February 25, 2011
No effect of single-dose intranasal insulin treatment on verbal memory and sustained attention in patients with schizophreniaXiaoduo Fan, Paul M Copeland, Emily Y Liu, et al.
Psychopharmacology|August 22, 2008
A placebo-controlled study of sildenafil effects on cognition in schizophreniaDonald C Goff, Corinne Cather, Oliver Freudenreich, et al.
Pageof 17